Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Option Care Health (OPCH) EBITDA (2016 - 2025)

Historic EBITDA for Option Care Health (OPCH) over the last 17 years, with Q3 2025 value amounting to $50.4 million.

  • Option Care Health's EBITDA rose 549.77% to $50.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $205.2 million, marking a year-over-year increase of 400.54%. This contributed to the annual value of $207.9 million for FY2024, which is 2032.01% down from last year.
  • Per Option Care Health's latest filing, its EBITDA stood at $50.4 million for Q3 2025, which was up 549.77% from $48.8 million recorded in Q2 2025.
  • Over the past 5 years, Option Care Health's EBITDA peaked at $117.7 million during Q2 2023, and registered a low of $1.2 million during Q1 2021.
  • In the last 5 years, Option Care Health's EBITDA had a median value of $47.7 million in 2024 and averaged $49.2 million.
  • Per our database at Business Quant, Option Care Health's EBITDA skyrocketed by 328893.44% in 2022 and then plummeted by 5569.53% in 2024.
  • Over the past 5 years, Option Care Health's EBITDA (Quarter) stood at $75.0 million in 2021, then plummeted by 41.11% to $44.2 million in 2022, then rose by 15.66% to $51.1 million in 2023, then grew by 20.71% to $61.7 million in 2024, then fell by 18.36% to $50.4 million in 2025.
  • Its EBITDA was $50.4 million in Q3 2025, compared to $48.8 million in Q2 2025 and $44.3 million in Q1 2025.